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Purpose: We tested the hypothesis that loss of angiotensin converting enzyme 2 
(ACE2) within diabetic HS/PCs would be detrimental to HS/PC reparative function, 
and alter their ability to contribute to vascular remodeling in human subjects and 
rodent models of DR.   
Methods: Subjects (n=52) were recruited as controls (n=13) or diabetics (n=39) 
with either no DR, mild non-proliferative DR (NPDR), moderate NPDR, severe 
NPDR or proliferative DR (PDR). Fluorescein angiograms were analyzed using 
Vessel Generation Analysis (VESGEN) software in a cohort of subjects.  CD34+ 
HS/PCs were isolated from peripheral blood. RAS gene expression and migration 
was measured. Diabetic ACE2 knockout (KO)/C57BL/6-Ins2 (Akita) mice at 3, 6 
and 9 months of diabetes were compared to age-matched controls. Bone marrow 
HS/PC populations were analyzed by flow cytometry and migration and 
proliferation studies performed.  
Results: ACE2 gene expression in human CD34+ cells from diabetics without DR 
was increased compared to controls (p=0.0437). Mas receptor mRNA was also 
increased in diabetics without DR, but reduced with the onset of NPDR 
(p=0.0002), suggesting a loss of compensation. DR was associated with CD34+ 
cell migratory dysfunction. By VESGEN analysis, vessel density measured by 
several confirming parameters in early NPDR (n=3) was greater than in normal 
retina (n=6) in both arteries and veins, which suggests active retinal remodeling. 
ACE2KO-Akita and Akita cohorts showed reduced retinal thickness by OCT at 9 
months of diabetes. Absence of ACE2 in 9-month Akita mice led to an accelerated 
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increase in acellular capillaries compared to diabetic alone. Electroretinogram 
(ERG) in ACE2KO-Akita mice resulted in persistent deterioration of the neural 
retina. Reparative function studies showed that ACE2KO exacerbated 
diabetes-induced impairment of LK cell migration and proliferative functions as 
early as 3-month of diabetes (p=0.0019).  
Conclusions: Retinopathy and adverse vascular remodeling in subjects with 
diabetes was associated with a loss of the protective arm of RAS in HS/PCs. Loss 
of ACE2 exacerbated vascular dysfunction in diabetic mice.  
 
